| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |